Screener
Theriva Biologics TOVX Q1 2026 earnings
Reported May 7, 2026 · Before market open
Revenue$300.0KIn line
EPS-$0.05In line
Revenue estimate$300.0K
EPS estimate-$0.05
Next report
Nov 17, 2026 (in 2 months)EPS estimate-$0.07
Versus estimates
Revenue
Q1 2026$300.0KIn line
FAQ
- When did Theriva Biologics report Q1 2026 earnings?
- Theriva Biologics (TOVX) reported Q1 2026 earnings on May 7, 2026 before market open.
- What were Theriva Biologics's Q1 2026 revenue and EPS?
- Theriva Biologics reported revenue of $300.0K and eps of $-0.05 for Q1 2026.
- Did Theriva Biologics beat estimates in Q1 2026?
- Revenue beat the consensus estimate of $300.0K by -. EPS beat the consensus estimate of $-0.05 by $0.00.
- How did Theriva Biologics's Q1 2026 results compare year-over-year?
- Compared to the same quarter a year prior, eps grew 96.8% from $-1.55.
- Where can I find Theriva Biologics's Q1 2026 SEC filings?
- You can read the 8-K earnings release (0001104659-26-055679) and the 10-Q periodic report (0001104659-26-055689) directly on SEC EDGAR. The filing index links above go to sec.gov.
